What is the appropriate Augmentin (amoxicillin + clavulanate) oral suspension dose for an 8‑year‑old with otitis media weighing 113 lb (≈51 kg)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Augmentin Dosing for 8-Year-Old with Otitis Media (113 lb)

For this 8-year-old child weighing 113 lb (51 kg) with acute otitis media, prescribe high-dose amoxicillin-clavulanate (Augmentin) at 90 mg/kg/day of the amoxicillin component with 6.4 mg/kg/day of clavulanate, divided into 2 doses daily, which equals approximately 2,295 mg of amoxicillin twice daily (4,590 mg total daily dose). However, this significantly exceeds the standard adult maximum dose of 1,500 mg/day, creating a clinical dilemma.

The Weight-Based Dosing Problem

At 51 kg, strict adherence to the American Academy of Pediatrics guideline recommendation of 90 mg/kg/day 1 would require:

  • Amoxicillin component: 4,590 mg/day (2,295 mg twice daily)
  • Clavulanate component: 326 mg/day (163 mg twice daily)

This exceeds the typical adult maximum dose by more than 3-fold, which was not addressed during guideline formulation 2.

Practical Dosing Recommendation

In real-world practice, cap the dose at the standard adult maximum of 1,500 mg/day of amoxicillin (750 mg twice daily) using the 14:1 formulation to minimize diarrhea 1. This approach is supported by:

  • Research showing that physicians commonly prescribe significantly lower doses in heavier children (mean 40.4 mg/kg/day vs. 74.2 mg/kg/day in children ≤20 kg) 2
  • Survey data indicating 66.7% of guideline committee members would prescribe the standard adult dose when calculated doses exceed it 2
  • Clinical trial data demonstrating high efficacy (96% bacterial eradication) even with the high-dose regimen in the studied population 3

Specific Liquid Formulation Options

For oral suspension, use Augmentin ES-600 (600 mg amoxicillin/42.9 mg clavulanate per 5 mL) 4:

  • Dose: 6.25 mL (750 mg amoxicillin) twice daily
  • This provides the 14:1 ratio that reduces diarrhea risk 1, 5

Alternative: If ES-600 is unavailable, standard Augmentin suspension can be used, but expect higher rates of diarrhea (26.7% vs. 9.6% with the 14:1 formulation) 5.

Duration of Therapy

Prescribe for 10 days 1. While 5-7 day courses are recommended for children ≥2 years in guidelines, the evidence shows:

  • 10-day courses remain standard practice (75% of prescriptions) 6
  • 5-day courses showed lower efficacy in younger children 5
  • Treatment failure and recurrence are rare (2.2% and 3.3% respectively) with 10-day courses 7

When to Use Augmentin vs. Plain Amoxicillin

Use amoxicillin-clavulanate (Augmentin) as first-line if 1:

  • Child received amoxicillin in the previous 30 days
  • Concurrent purulent conjunctivitis (otitis-conjunctivitis syndrome)
  • Coverage for β-lactamase-producing organisms (H. influenzae, M. catarrhalis) is desired

Otherwise, plain high-dose amoxicillin is preferred as first-line due to narrower spectrum and lower adverse event rates 1.

Clinical Pearls and Caveats

  • Diarrhea risk: Protocol-defined diarrhea occurs in 11-13% of children on high-dose amoxicillin-clavulanate 4, 3. The 14:1 ratio formulation significantly reduces this risk 1, 5
  • Compliance: Twice-daily dosing improves adherence (82.8% vs. 73.3% for three-times-daily) 8
  • Treatment failure: Occurs in only 5.4% of cases with amoxicillin, regardless of β-lactamase production 9, supporting its continued first-line use
  • Obesity consideration: The guideline did not address dosing in heavier children 2, making clinical judgment necessary when calculated doses exceed adult maximums

Expected Outcomes

With appropriate dosing, expect 3, 9:

  • Bacterial eradication: 96% overall, including 91% for penicillin-resistant S. pneumoniae
  • Clinical improvement: 74% by day 5,89% by end of therapy
  • Treatment failure: <6% across all antibiotic agents 7

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.